Niyati Skaria, M.D.
Investigator
Niyati Skaria, MD is a board-certified pediatric endocrinologist currently practicing with Sutter Medical Group in Sacramento, California. She specializes in the diagnosis and management of endocrine disorders in children and adolescents, with a particular focus on diabetes and metabolic conditions.
Dr. Skaria earned her medical degree from St. George’s University and completed her pediatric residency at NYU Langone Hospital–Long Island. She went on to complete a fellowship in pediatric endocrinology at Stony Brook Children’s Hospital, where she also engaged in clinical research on continuous glucose monitoring in pediatric patients with diabetic ketoacidosis.
Prior to joining Sutter Medical Group, Dr. Skaria practiced for nearly a decade at the Center of Excellence in Diabetes and Endocrinology in Sacramento. Her academic contributions include presentations at national conferences and award-winning research recognized by the Endocrine Society.
Dr. Skaria is committed to advancing pediatric endocrine care through evidence-based practice, patient education, and multidisciplinary collaboration.
Research studies
An Observational Study of VYKAT™ XR (Diazoxide Choline Extended-Release Tablets) in Patients With Prader-Willi Syndrome (PWS)
Clinical trials
- Clinical trial
Congenital Adrenal Hyperplasia in Pediatrics CRN04894-13
A Phase 2/3 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Atumelnant Treatment in Pediatric Participants With Congenital Adrenal Hyperplasia Including a Long-Term Extension
Status: Coming Soon
- Clinical trial
Growth Hormone Deficiency (GHD) LUM-201-10 OraGrowth
A Multicenter, 12-Month, Randomized, Double Blind, Placebo-Controlled Phase 3 Efficacy and Safety Study of Daily Oral LUM-201 in Naïve-to-Treatment, Prepubertal Children With Growth Hormone Deficiency (GHD)
Status: Open to Enrollment
- Clinical trial
Idiopathic Short Stature ASND0047 HighLiGHts
A Pivotal, Parallel-Arm, Phase 3, Open-Label, Active-controlled, Global, Multicenter, Randomized Basket Trial Investigating the Efficacy and Safety of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Children and Adolescents With Growth Failure or Short Stature Due to Growth Hormone Sufficient Disorders - Turner Syndrome, SHOX Deficiency, Small for Gestational Age, and Idiopathic Short Stature
Status: Open to Enrollment